Posted by Michael Wonder on 10 Apr 2017
Cancer drug Kadcyla approved for use by NHS Scotland
10 April 2017 - A breast cancer drug which is being withdrawn in England because it is too expensive is being made available on the NHS in Scotland.
Kadcyla is used to treat an aggressive, advanced type of breast cancer known as HER2 positive.
The SMC said the drug would enable patients to spend "more time with their families and in some cases return to work".
Scottish health secretary Shona Robison said the SMC made a "good decision".
